Blood Screening Market Analysis By Industry Value, Market Size, Top Companies And Growth Forecast by 2026

Worldwide demand for blood screening products and procedures remains on an uptrend, majorly driven by the alarmingly high rate of infectious disease spread. Chronic disease prevalence, and the expansion of high-risk population further elevate the prospects of global blood screening market.

In a new ongoing research study, Fairfield Market Research intends to provide a detailed analysis and growth forecast of blood screening market over the next few years. The COVID-19 pandemic came as a crisis, as well as a sea of opportunities for the participants in global blood screening market space, says the report.

Looking For a Sample Copy of This Report? Request the Same Here: https://www.fairfieldmarketresearch.com/report/blood-screening-market/request-sample

Sales of blood screening reagents and kits grow stronger based on their easier market availability, and ability to deliver reliable, faster, and specific results, especially when it comes to specific detection of transfusion transmissible infections (TTIs). While reagents and kits maintain their primacy, the initial findings also suggest that the nucleic acid amplification test (NAT) will continue to be the most sought-after blood screening technology owing to its superior sensitivity, and high specificity for viral nucleic acid. Demand will be notable at hospitals, whereas blood banks are likely to represent the most lucrative end-user segment.

Key Competitors in Global Blood Screening Landscape

1. GE Healthcare
2. Abbott Laboratories
3. Becton
4. Dickinson and Company
5. Bio-Rad Laboratories
6. Thermo Fisher Scientific Inc.
7. F. Hoffmann-La Roche Ltd
8. Merck KGaA
9. Perkinelmer
10. Grifols
11. S.A.
12. Ortho Clinical Diagnostics Inc.
13. bioMérieux Inc.
14. Danaher Corporation
15. Siemens Healthineers

Adoption of Blood Screening Upbeat with Advent of Molecular Biology Techniques

A number of tests are generally recommended during pregnancy to be able to identify any potential prenatal abnormalities. With the advent of technology enabling this, demand for blood screening procedures and products will also be on the rise. The growing significance of molecular biology techniques like next-generation sequencing (NGS), western blot assay, and enzyme-linked immunosorbent assay (ELISA) further point to a host of opportunities emerging for blood screening market players. Research highlights stronger adoption projections with the rise of microbiological screening and multiplexing technology for HBV, HCV, HIV, and pathogen reduction. There are certain viral infectious disease agents like hepatitis, HIV-1 and -2, and HTLV that can only be detected through blood screening procedures. This promises a steady stream of demand generation opportunities in blood screening market.

Market in Asia Pacific Develops High Growth Potential

North America continues to be a prime market for a variety of blood screening products and procedures. The market here will receive an impetus from the supportive regulatory environment, favourable reimbursement scenario, and solid expansion of the diagnostics sector. On the other side, growing demand for blood screening tests across several economies in the Asia Pacific is all set to create a fertile ground for the market here.

While higher chronic disease prevalence, noncommunicable disease spread, and frequent epidemiological crises collectively form a favorable growth environment for market participants, the rapid progress in the field of diagnostics across the Asian subcontinent is all set to complement this demand surge in the IV bags market.

Do You Have Any Query or Specific Requirements? Request Customization of Report: https://www.fairfieldmarketresearch.com/report/blood-screening-market/request-customization

Moreover, the market here is projected to benefit from a large number of initiatives like blood donation campaigns, blood transfusion drives, and public education and awareness programmes based around the impact of disease transmission during blood transfusion. Lack of standardisation will however remain a challenge to the blood transfusion landscape in long run, thereby influencing the blood screening space.

Trending Reports by Fairfield Market Research-

Vehicle Battery Market: https://www.globenewswire.com/en/news-release/2022/05/16/2444120/0/en/Vehicle-Battery-Market-Size-to-Exceed-US-43-3-Bn-by-2030-End-China-to-Remain-Global-Hub-Fairfield-Market-Research.html

Lithium Mining Market: https://www.globenewswire.com/en/news-release/2022/05/12/2442146/0/en/Global-Lithium-Mining-Market-Stood-at-US-829-73-Mn-in-2019-and-is-Expected-to-Reach-US-1-630-30-Mn-by-2025-Registering-a-CAGR-of-26-3-Fairfield-Market-Research.html

Hemophilia Treatment Market: https://www.globenewswire.com/en/news-release/2022/05/10/2439938/0/en/Hemophilia-Treatment-Market-is-Expected-to-be-Reach-US-21-349-6-Million-by-2027-at-a-Healthy-Pace-of-5-2-CAGR-Fairfield-Market-Research.html

Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA +1 (844) 3829746 (Toll-free)
Email: sales@fairfieldmarketresearch.com
Web: https://www.fairfieldmarketresearch.com/
Follow Us: https://bit.ly/3voYIm9

About Us :-
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values and eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

This release was published on openPR.